SCHEMBL8832011

SCHEMBL8832011

Brc1ccc2nc3c(nc2c1)[nH]c1ccccc13

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.71
TP53 P04637 2/20 0.71
CASP1 P29466 2/20 0.71
RAB9A P51151 2/20 0.71
MAPK10 P53779 2/20 0.71
CASP7 P55210 2/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
POLB P06746 2/20 0.71
MAPT P10636 8/20 0.69
CYP1A2 P05177 3/20 0.69
CYP3A4 P08684 2/20 0.69
CYP2C9 P11712 2/20 0.69
CYP2C19 P33261 2/20 0.69
MAPK1 P28482 1/20 0.69
AURKA O14965 2/20 0.55
PLK4 O00444 1/20 0.55
CHEK1 O14757 1/20 0.55
DAPK3 O43293 1/20 0.55
CHEK2 O96017 1/20 0.55
CDK1 P06493 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832004 0.84 RAB9A (0.65) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL278729 0.84 RAB9A (1.00) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL29572859 0.84 RAB9A (1.00) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL8832035 0.82 NPC1 (0.71) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL278691 0.80 NPC1 (0.72) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL9436882 0.80 NPC1 (0.72) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL9706300 0.78 MAPK1 (0.48) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL3257675 0.77 MAPK9 (0.70) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL2112432 0.77 NPC1 (0.55) NPC1TP53CASP1RAB9AMAPK10
SCHEMBL9706105 0.76 MAPK1 (0.51) NPC1TP53CASP1RAB9AMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 EP disclosed